# EDGAR Filing Document

**Accession Number:** 0001710155
**File Stem:** 0001710155-23-000015
**Filing Date:** 2023-3
**Character Count:** 5187
**Document Hash:** e4214fb5b26670de5cf596893350db8e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001710155-23-000015.hdr.sgml**: 20230310

**ACCESSION NUMBER**: 0001710155-23-000015

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20230309

**ITEM INFORMATION**: Regulation FD Disclosure

**FILED AS OF DATE**: 20230310

**DATE AS OF CHANGE**: 20230309

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** National Vision Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001710155
- **STANDARD INDUSTRIAL CLASSIFICATION:** OPHTHALMIC GOODS [3851]
- **IRS NUMBER:** 464841717
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1230

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38257
- **FILM NUMBER:** 23720888

**BUSINESS ADDRESS:**
- **STREET 1:** 2435 COMMERCE AVENUE
- **STREET 2:** BLDG. 2200
- **CITY:** DULUTH
- **STATE:** GA
- **ZIP:** 30096-4980
- **BUSINESS PHONE:** (770) 822-3600

**MAIL ADDRESS:**
- **STREET 1:** 2435 COMMERCE AVENUE
- **STREET 2:** BLDG. 2200
- **CITY:** DULUTH
- **STATE:** GA
- **ZIP:** 30096-4980

?xml version="1.0" ? eye-20230309

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**_______________________________________________________________________**

**FORM 8-K** 

**_______________________________________________________________________**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of Earliest Event reported):**

**March 9, 2023**

**_______________________________________________________________________**

**National Vision Holdings, Inc.** 

(Exact name of registrant as specified in its charter)

**_______________________________________________________________________**

**Commission file number 001-38257** 

---

| | | |
|:---|:---|:---|
| **Delaware** | **Delaware** | **46-4841717** |
| (State or other jurisdiction of<br>incorporation or organization) | (State or other jurisdiction of<br>incorporation or organization) | (I.R.S. Employer<br>Identification No.) |
| **2435 Commerce Ave.** | **2435 Commerce Ave.** | |
| **Building 2200** | **Building 2200** | **30096** |
| **Duluth,** | **Georgia** | (Zip Code) |
| (Address of principal executive offices) | (Address of principal executive offices) | |

---

**(770) 822-3600** 

(Registrant's telephone number, including area code)

**_______________________________________________________________________**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐&nbsp;&nbsp;&nbsp;&nbsp;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.42)

☐&nbsp;&nbsp;&nbsp;&nbsp;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common stock, par value $0.01 per share | EYE | Nasdaq |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

&nbsp;&nbsp;&nbsp;&nbsp;If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐

------

**Item 7.01 Regulation FD Disclosure.**

In connection with participation in upcoming investor meetings and conferences, National Vision Holdings, Inc. (the "Company") today announced a status update to its stock repurchase authorization ("Repurchase Authorization") following its earnings call held on March 1, 2023, at which the Company indicated there was $50 million remaining. As of the date hereof, the Company has repurchased an additional $25 million under the Repurchase Authorization. The timing and amounts of any further repurchases under the Repurchase Authorization will depend on a variety of factors, including the market price of the Company's shares, general market and economic conditions, legal requirements and tax implications.

------

 **Signatures**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | | National Vision Holdings, Inc. |
| Date: March 9, 2023 | By: | /s/ Jared Brandman |
|  | Name: | Jared Brandman |
|  | Title: | Senior Vice President, General Counsel and Secretary |

---